6-KThe Wire
Innate Pharma SA files 6-K
Filed May 6, 2026 · 1mo ago · Accession 0001628280-26-030874
Plain English
Innate Pharma S.A. announced on May 6, 2026, that it has entered into a definitive agreement to sell its subsidiary, Innate Pharma Inc., to Sanofi. This transaction is expected to close in the third quarter of 2026.
Filing details
- Company
- Innate Pharma SA
- Ticker
- IPHA
- CIK
- 1598599
- Form type
- 6-K
- Filing date
- May 6, 2026
- Report date
- May 6, 2026
- Document
- a260506_6k.htm
- Size
- 23 KB